GERON CORP — Investor Relations & Filings
Filings indexed
1,021
across all filing types
Latest filing
2026-05-08
Major Shareholding Noti…
Country
US
United States of America
Listing
US
GERN
Geron Corp is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for hematologic malignancies. Its lead product, imetelstat, is a first-in-class telomerase inhibitor approved for the treatment of certain blood cancers. The company's scientific approach targets telomerase to alter the course of hematologic myeloid malignancies, with the goal of extending and enhancing the lives of patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2026 | 2026-05-08 | English | |
| 10-Q - GERON CORP (0000886744) (Filer) | 2026-05-06 | English | |
| ARS - GERON CORP (0000886744) (Filer) | 2026-04-07 | English | |
| DEFA14A | 2026-04-07 | English | |
| DEF 14A - GERON CORP (0000886744) (Filer) | 2026-04-07 | English | |
| SCHEDULE 13G/A - GERON CORP (0000886744) (Subject) | 2026-03-26 | English |
Browse filings by year
18 yearsMarket data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Innate Pharma
Clinical-stage biotech developing immunotherapies for cance…
|
IPH | FR | Manufacturing |
|
Inner Mongolia Furui Medical Science Co.,Ltd.
Specializes in integrated diagnosis and treatment of chroni…
|
300049 | CN | Manufacturing |
|
InnoCan Pharma Corporation
Pharmaceutical tech company focused on innovative cannabino…
|
INNO | CA | Manufacturing |
|
InnoCare Pharma Limited
Developing and commercializing innovative drugs for cancer …
|
9969 | KY | Manufacturing |
|
INNOCARE PHARMA LIMITED
Develops molecularly targeted therapies for cancer and auto…
|
688428 | CN | Manufacturing |
|
INNOGENE Co., Ltd.
Develops and distributes anti-aging products for skin regen…
|
344860 | KR | Manufacturing |
|
INNOVA CAPTAB LIMITED
Integrated pharmaceutical CDMO specializing in R&D, manufac…
|
INNOVACAP | IN | Manufacturing |
|
Innovent Biologics, Inc.
Develops and commercializes innovative biopharma drugs for …
|
1801 | KY | Manufacturing |
|
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.
Provides IVD reagents and clinical instruments for rapid di…
|
688253 | CN | Manufacturing |
|
INOVIO PHARMACEUTICALS, INC.
A clinical-stage biotech firm developing DNA medicines deli…
|
INO | US | Manufacturing |
GERON CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GERON CORP (id: 32370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.